Cart
sales@molnova.com
Home - Products - Others - Other Targets - Luteolin-7-O-alpha-L-arabinopyranosyl (1->6)-beta-D-glucopyranoside

Luteolin-7-O-alpha-L-arabinopyranosyl (1->6)-beta-D-glucopyranoside

CAS No. 52714-82-6

Luteolin-7-O-alpha-L-arabinopyranosyl (1->6)-beta-D-glucopyranoside( —— )

Catalog No. M32239 CAS No. 52714-82-6

Reference standards.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 641 In Stock
50MG Get Quote In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock
Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    Luteolin-7-O-alpha-L-arabinopyranosyl (1->6)-beta-D-glucopyranoside
  • Note
    Research use only, not for human use.
  • Brief Description
    Reference standards.
  • Description
    Reference standards.
  • In Vitro
    Luteolin-7-O-α-L-arabinopyranosyl (1→6)-β-D-glucopyranoside (compound 2) shows significant antiradical activity in the 1,1-diphenyl-2-picrylhydrazyl (DPPH) assay (EC50=41.4 μM).
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    52714-82-6
  • Formula Weight
    580.49
  • Molecular Formula
    C26H28O15
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO, Pyridine, Methanol, Ethanol, etc.
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • Dibenzosuberol

    It is an organic compound used as Pharmaceutical intermediate.

  • dCeMM3?

    2-(1H-benzimidazol-2-ylsulfanyl)-N-(5-chloropyridin-2-yl)acetamide is compound used for high-throughput Screening assay.

  • MID-1

    MID-1 is an inhibitor of MG53-IRS-1 (Mitsugumin 53-Insulin Receptor Substrate-1) interaction.?It disrupts molecular association of MG53 with IRS-1 and abolishes MG53-induced IRS-1 ubiquitination and degradation in skeletal muscle, leading to elevated IRS-1 expression level and increased insulin signaling and glucose uptake.

Sign In Join Free